Showing 1 - 4 results of 4 for search 'Till Wallrabenstein', query time: 0.02s Refine Results
  1. 1
    Upfront Taxane Could Be Superior to Pegylated Liposomal Doxorubicin (PLD): A Retrospective Real-World Analysis of Treatment Sequence Taxane–PLD versus PLD–Taxane in Patients with Metastatic Breast Cancer

    Upfront Taxane Could Be Superior to Pegylated Liposomal Doxorubicin (PLD): A Retrospective Real-World Analysis of Treatment Sequence Taxane–PLD versus PLD–Taxane in Patients with M... by Till Wallrabenstein, Anton Oseledchyk, Eveline Daetwyler, Christoph Rochlitz, Marcus Vetter

    Published 2023-10-01
    Get full text
    Article
  2. 2
    Much has changed in the last decade except overall survival: A Swiss single center analysis of treatment and survival in patients with stage IV non-small cell lung cancer.

    Much has changed in the last decade except overall survival: A Swiss single center analysis of treatment and survival in patients with stage IV non-small cell lung cancer. by Till Wallrabenstein, Jessica Del Rio, Arnoud J Templeton, Martin Buess

    Published 2020-01-01
    Get full text
    Article
  3. 3
    Corticosteroid-resistant immune-related adverse events: a systematic review

    Corticosteroid-resistant immune-related adverse events: a systematic review by Laura C Cappelli, Jarushka Naidoo, Alfred Zippelius, Heinz Läubli, David König, Eveline Daetwyler, Till Wallrabenstein

    Published 2024-01-01
    Get full text
    Article
  4. 4
    Real-World Data of Combined Immunochemotherapy in Patients With Nonsquamous Advanced NSCLC. A Single-Center Retrospective Study

    Real-World Data of Combined Immunochemotherapy in Patients With Nonsquamous Advanced NSCLC. A Single-Center Retrospective Study by Till Wallrabenstein, MD, Maximilian Mamot, MSc, Eveline Daetwyler, MD, David König, MD, Sacha I. Rothschild, MD, PhD

    Published 2023-05-01
    Get full text
    Article

Search Tools: